TokenPost·

GT Biopharma Posts $3.5 Million Q3 Loss, Projects Runway Into Q3 2027

Your call?

It had about $10 million in cash on Sept. 30, 2026, after posting net income of $8.3 million in the year-earlier quarter.

Share

More news